LeMusique/iStock via Getty Images
With trading paused midweek for the Juneteenth holiday on Thursday, the upcoming earnings calendar is lighter than usual—but still features several notable names across retail, consulting, housing, and cannabis.
Key reports to watch include Aurora Cannabis (NASDAQ:ACB), The Kroger (NYSE:KR), and Accenture (NYSE:ACN), offering insights into consumer behavior, health trends, and enterprise tech demand. Additional updates are expected from Digital Turbine (NASDAQ:APPS), Lennar Corporation (NYSE:LEN), Darden Restaurants (NYSE:DRI), Smith & Wesson Brands (NASDAQ:SWBI), Jabil (NYSE:JBL), and CarMax (NYSE:KMX), providing a cross-sector look at economic resilience and shifting spending patterns.
Below is a rundown of major earnings reports due in the week of June 16 to June 20:
Monday, June 16
Lennar (NYSE:LEN)
Lennar (LEN) is set to report its Q2 earnings after the market closes on Monday, with analysts expecting a Y/Y decline in both EPS and revenue. As macroeconomic headwinds persist, investors will be focused on how rising rates and affordability issues are impacting homebuilders’ margins and order volumes.
Both Seeking Alpha’s Quant Rating system and sell-side analysts maintain a Hold rating, citing growth concerns and a cautious outlook for the housing sector.
SA contributor The Alpha Sieve also rates the stock Hold, noting that while LEN has underperformed peers and large caps year-to-date, the upcoming report may offer positive surprises, given seasonally strong home orders and muted expectations. Gross margins may remain under pressure as the company increases buyer incentives, though construction costs are stable for now. Valuation is no longer stretched, but medium-term earnings visibility remains limited. Technically, the stock appears to be forming a bottom and no longer screens as overbought compared to other housing names.
- Consensus EPS Estimates: $1.94
- Consensus Revenue Estimates: $8.19B
- Earnings Insight: The company has exceeded EPS expectations in 7 of the past 8 quarters, missing revenue estimates twice in that timeframe.
Also reporting: Powerfleet (NASDAQ:AIOT), ReNew Power (NASDAQ:RNW), Coda Octopus Group (NASDAQ:CODA), Digital Turbine (NASDAQ:APPS), PetMed Express (NASDAQ:PETS), High Tide (HITI), Globus Maritime (GLBS), and more.
Tuesday, June 17
Jabil (NYSE:JBL)
Jabil (JBL) is set to report its FQ3 results before the market opens on Tuesday, with analysts forecasting a nearly 23% Y/Y increase in profits. As investors look for signs of margin stability and growth beyond cyclical demand, Jabil’s positioning across sectors will be in focus.
While Wall Street analysts maintain a Buy rating, Seeking Alpha’s Quant Rating system suggests a Hold, reflecting caution around near-term volatility.
SA contributor Alpha Compounder remains constructive, highlighting Jabil’s resilience to tariff impacts due to its B2B model, where costs are often passed along the supply chain. The company’s strong manufacturing footprint in the U.S. and Mexico is seen as a strategic advantage amid reshoring trends. Jabil is also making moves in AI-related photonics, expanding with a new facility in India, while a recent pharma acquisition enhances its role in regulated healthcare manufacturing. Despite temporary revenue fluctuations, the company is generating growing free cash flow and trades at a compelling valuation, making it a name to watch this quarter.
- Consensus EPS Estimates: $2.32
- Consensus Revenue Estimates: $7.07B
- Earnings Insight: The company has exceeded EPS expectations in 7 of the past 8 quarters, missing revenue estimates twice in that period.
Also reporting: TEN (TEN), Vince Holding (VNCE), Wiley (WLY), Kirkland’s (KIRK), Beyond Air (XAIR), La-Z-Boy (LZB), and more.
Wednesday, June 18
Aurora Cannabis (NASDAQ:ACB)
Aurora Cannabis (ACB) is slated to report its FQ4 results before the market opens on Wednesday. Both Wall Street analysts and Seeking Alpha’s Quant Rating system currently rate the stock a Buy, reflecting a more optimistic view amid ongoing sector volatility.
SA Investing Group Leader Stone Fox Capital remains constructive on ACB, citing recent improvements in cost controls, positive adjusted EBITDA trends, and the company’s continued efforts to streamline operations. With a strategic focus on medical cannabis, Aurora has been working to differentiate itself from recreational peers by targeting higher-margin international markets. While the cannabis sector as a whole has struggled, Aurora’s improving fundamentals and disciplined capital management are drawing cautious optimism from analysts and investors alike heading into the Q4 report.
- Consensus EPS Estimates: $0.10
- Consensus Revenue Estimates: $61.83M
- Earnings Insight: The company has exceeded EPS expectations in 3 of the past 8 quarters, and revenue estimates in 6 of those reports.
Also reporting: GMS (GMS), LiveOne (LVO), Smith & Wesson Brands (NASDAQ:SWBI), and more.
Thursday, June 19
Markets closed for the Juneteenth holiday.
Friday, June 20
Kroger (NYSE:KR)
Kroger (KR) is set to release its FQ1 results before the market opens on Friday, as investors assess how the grocery giant is navigating cost pressures and shifting consumer behavior.
Recently, Kroger announced plans to hire 15,000 employees across roles including cashiers, pharmacy techs, and delivery drivers, signaling operational expansion amid rising labor and food costs.
Wall Street analysts currently rate the stock a Buy, while Seeking Alpha’s Quant Rating system downgraded it to Hold last month, reflecting valuation concerns.
SA contributor FutureRich Investing takes a more bearish stance, rating KR a Sell, arguing that despite solid 5-year performance, financial growth does not justify the stock’s elevated valuation. The company’s P/E ratio has surged disproportionately relative to its modest revenue, income, and free cash flow growth, leading to concerns the stock is overpriced. Comparisons to premium-priced peers like Costco (COST), the author notes, mask fundamental overvaluation in intrinsic models.
- Consensus EPS Estimates: $1.46
- Consensus Revenue Estimates: $45.29B
- Earnings Insight: The company has topped EPS estimates in consecutive past 8 quarters, and revenue estimates 3 times in those reports.
Accenture (NYSE:ACN)
Accenture (ACN) is set to report its FQ3 results before the market opens on Friday, as investors evaluate how the consulting giant is managing through macro uncertainty and slower tech spending.
The stock is down roughly 11% year-to-date, reflecting concerns around growth and valuation.
Wall Street analysts maintain a Buy rating, pointing to long-term potential in AI and digital transformation, while Seeking Alpha’s Quant Rating system holds at Neutral (Hold) due to modest growth trends and valuation pressure.
SA contributor Gytis Zizys also rates the stock a Hold, citing limited near-term upside despite expectations for slight revenue and EPS beats. He’s closely watching for stronger GenAI momentum, improved booking trends, and operational efficiencies. However, ongoing margin pressure, macroeconomic headwinds, and uncertainties around federal contracts keep the outlook cautious, with potential downside risks before any meaningful recovery.
- Consensus EPS Estimates: $3.32
- Consensus Revenue Estimates: $17.30B
- Earnings Insight: Accenture has topped EPS estimates in 7 of the past 8 quarters, and revenue estimates 6 times in those reports.
Also reporting: Kroger (KR), Accenture (ACN), Darden Restaurants (NYSE:DRI), CarMax (NYSE:KMX), and more.